Breast cancer resistance protein in pharmacokinetics and drug–drug interactions

Author： Xia Cindy Q Yang Johnny J Gan Liang-Shang

ISSN： 1742-5255

Source： Expert Opinion on Drug Metabolism and Toxicology, Vol.1, Iss.4, 2005-12, pp. : 595-611

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Drug transport by breast cancer resistance protein

By Poguntke Maren Hazai Eszter Fromm Martin F Zolk Oliver

Expert Opinion on Drug Metabolism and Toxicology, Vol. 6, Iss. 11, 2010-11 ,pp. : 1363-1384

Informa Healthcare

Access to resources Recommend Favorite

ABC Multidrug Transporters: Target for Modulation of Drug Pharmacokinetics and Drug-Drug Interactions

Current Drug Targets, Vol. 12, Iss. 5, 2011-05 ,pp. : 600-620

Bentham Science Publishers

Access to resources Recommend Favorite

Pharmacokinetics and Metabolic Drug Interactions

Current Clinical Pharmacology, Vol. 1, Iss. 1, 2006-01 ,pp. : 5-20

Bentham Science Publishers

Access to resources Recommend Favorite

Biomarkers and Multiple Drug Resistance in Breast Cancer

Current Cancer Drug Targets, Vol. 6, Iss. 5, 2006-08 ,pp. : 365-384

Bentham Science Publishers

Access to resources Recommend Favorite

Nanobiotechnological Approaches to Overcome Drug Resistance in Breast Cancer

Current Cancer Drug Targets, Vol. 15, Iss. 7, 2015-01 ,pp. : 544-562

Bentham Science Publishers

Access to resources Recommend Favorite